Reprocell Inc operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Reprocell Inc with three other
pharmaceutical manufacturers in Asia:
Jia Jie Biomedical Co Ltd
sales of 270.29 million Taiwanese Dollars [US$9.61 million]
Bioalpha Holdings Bhd
(36.52 million Malaysian Ringgits [US$8.85 million]
Nova Wellness Group Bhd
based in MALAYSIA
(34.27 million Malaysian Ringgits [US$8.31 million]
of which 80%
was House Brand).
During the year ended March of 2020, sales at
Reprocell Inc were ¥1.20 billion (US$11.10 million).
increase of 10.2%
versus 2019, when the company's sales were ¥1.09 billion.
Sales of Research Support Business saw an increase
20.0% in 2020, from
¥934.21 million to ¥1.12 billion.
Not all segments of Reprocell Inc experienced an increase in sales in 2020:
sales of Medical Business fell 48.6% to ¥79.30 million.